Director TitleAgeSince
Chairman 67 -
Director/Board Member 56 2011-04-13
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-100.00% - - 9
+1.23%+1.08%+15.52%+80.84% 48.15B
-0.23%-1.65%+67.15%+109.36% 35.59B
+1.61%+0.15%-2.75%+39.18% 11.9B
+0.46%-0.16%+17.85%+89.14% 11.85B
+0.93%+2.87%+34.92%+137.61% 9.31B
+3.37%-0.10%+51.64%-4.77% 7.02B
-0.42%+0.25%+16.05%+34.73% 6.91B
-.--%+0.14% - - 6.79B
+0.18%-1.90%+0.63%+211.00% 6.55B
Average +0.71%-0.61%+25.13%+87.14% 16.01B
Weighted average by Cap. +0.74%-0.68%+30.00%+88.70%
Logo Shengtai Pharmaceutical, Inc.
Shengtai Pharmaceutical, Inc. (Shengtai), through its wholly owned subsidiary, Weifang Shengtai Pharmaceutical Inc., is a producer of pharmaceutical-grade glucose in China. The Company's products include pharmaceutical-grade glucose or dextrose, used for medical purposes, as well as other glucose and cornstarch products used for the food and beverage industry, and for industrial productions in China. The Company's glucose series include dextrose monohydrate (DMH), dextrose anhydrous, oral glucose dextrin and rough glucose for other processing purposes. Its starch series include pharmaceutical starch and edible corn starch. The Company's customers include healthcare institutions, food and beverage companies, pharmaceutical companies, medical supply exporters and medical supply. The Company also exports its products to approximately 70 different countries overseas, such as Japan, Singapore, Korea, Australia, Russia and India.
Employees
733
  1. Stock Market
  2. Stocks
  3. SGTI Stock